Evaluate the Mediators of Sensitivity and Resistance to Nivolumab Plus Ipilimumab in Patients With Advanced NSCLCs
Clinical trial NCT02350764 · COMPLETED
Trial details
- NCT number
- NCT02350764
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-20
- Primary completion
- 2023-09-25
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.